caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1942496286

Kathleen NenningerARNP

Nurse PractitionerDavenport, IAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
588
Unique beneficiaries
—
Total services
3,794
Distinct HCPCS
12
Medicare payment
$114K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 2,245 Nurse Practitioner providers in IA — top quintile (cohort median 312).
REFERRAL NETWORK

Where Kathleen Nenninger's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 9 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
METROPOLITAN MEDICAL LABORATORY, PLC86238
Ghasoub Harb
Urology · Davenport, IA
56349
William Rosen
Urology · Canby, MN
3392
GENESIS HEALTH SYSTEM3356
Jennifer Kolwey
Nurse Practitioner · Davenport, IA
2474
TRINITY MEDICAL CENTER2343
Megan Varcho
Nurse Practitioner · Davenport, IA
2360
Andrew Edwards
Family Practice · Bettendorf, IA
1134
TRINITY MEDICAL CENTER1129
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
475
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
15
Brand share
38.7%
Top prescribed drugs
Tamsulosin Hcl130 claims
Enzalutamide39 claims
Finasteride39 claims
Methenamine Hippurate37 claims
Darolutamide36 claims
QUALITY · MIPS · 2024
Final MIPS score
85.9
Quality
76.7
Cost
76.4
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.46%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$185
Payment records
2
By payment type
Education$185